We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic

By LabMedica International staff writers
Posted on 08 Dec 2020
The global viral RNA extraction kit market is projected to record significant growth in the years to come, driven by the ongoing COVID-19 pandemic as a number of biotech companies race against time to come up with a coronavirus vaccine.

These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.

Viral RNA extraction kits are intended for the purpose of separation of trace amounts of viral RNA from given samples, along with body fluids, plasma, serum, and blood. Additionally, the kits offer high quality outcome of viral Ribonucleic acid (RNA) for the purpose of downstream utilization in various applications, such as alternative PCR-based assays, microarrays, and RT-PCR. These kits are ready to use and are found in a wide variety of formats, such as multi-well, magnetic-based, and spin column for the purpose of better and higher output abilities. Few of the kits also offer synchronal assortment of Deoxyribonucleic acid (DNA).

Increased research and development activities, greater mechanization, and considerable technological progress made in the process of extraction is likely to propel growth of the global viral RNA extraction kit market in the years to come. Additionally, there has been increased demand for various user-friendly products, which is likely to augur well for the market. A surge in cases of various diseases, such as genetic disorders, cancer, dermatological diseases, and infectious diseases, has resulted in increased demand for extraction of viral RNA process in the field of molecular diagnostics. However, significantly low level penetration of products and a dearth of awareness among people in the under-developed markets is likely to limit the growth of the global viral RNA extraction kit market in the years to come. Geographically, the global viral RNA extraction kit market is likely to be dominated by the North America region. Increased government support, technological advancements, and significant R&D in pharmaceutical and biotechnology firms are likely to emerge as important factors for the growth of the North American viral RNA extraction kit market in the near future.

Related Links:
Transparency Market Research


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.